Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review

CONCLUSIONS: Treatment with DHE resulted in at least some improvement for most patients regardless of headache type or number of doses. Clinical trials stratified by headache type and comorbid factors could help clarify treatment algorithms to optimize patient outcomes.PMID:34105158 | DOI:10.1111/head.14117

Source: Headache - June 9, 2021 Category: Neurology Authors: Rasha Srouji Sara R Schenkel Peter Forbes Jennifer E Cahill Source Type: research